InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,235.20
(
0.21%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.43
(
-1.32%
)
Bitcoin
69,714.97
(
-2.43%
)

Replies to post #1215 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1215 on Enanta Pharmaceuticals Inc (ENTA)

DewDiligence

11/24/15 9:53 AM

#1218 RE: NY1972 #1215

NVS obtained its cyclophilin inhibitor from Debiopharm, who reclaimed the rights to the compound when NVS pulled out.